COMPREHENSIVE MALE CANCER PACKAGE
At the heart of this package are 6 cancer marker tests, which are crucial in detecting the presence of cancer in your body. These tests are designed to identify specific proteins and substances produced by cancer cells, allowing your doctor to detect the disease in its earliest stages.
In addition to the cancer marker tests, you will also receive an ultrasound of your whole abdomen and a doctor consultation. This gives you the opportunity to discuss the results of your tests, ask any questions you may have, and receive personalized recommendations for your next steps. Why wait? Book an appointment today!
Some of the profiles/ tests that we cover in this package are:
- Alpha Feto Protein (AFP): A protein normally made by the liver and yolk sac of a developing baby, AFP levels go down soon after birth and are not seen in a healthy adult. Its presence is elevated in potential cancers, including testicular and liver cancer, in men.
- CA-19.9: A protein that exists on the surface of certain cancer cells, CA 19.9 is shed by the tumour cells and can be detected by lab tests in blood and other body fluids. Elevated levels of the protein is an indicator of cancers such as pancreatic, colorectal, and gastric cancers in men.
- Carcino Embryonic Antigen (CEA): This is a protein present in the gastrointestinal tract during foetal life. Babies in the womb have high levels of CEA and after birth, levels drop dramatically. Therefore, the level of CEA in the blood is relatively low unless certain diseases, including certain cancers are present. Hence, this tumour marker is used to monitor the progression of cancer, particularly in those who have already been diagnosed with cancer.
- PSA- PSA is a protein produced by normal, as well as malignant, cells of the prostate gland. PSA may exist in two forms: It may be bound to another protein or float freely. Our panel measures both, total PSA and Free PSA. A person may have an increased risk of prostate cancer when they have higher levels of total PSA and lower levels of free PSA. Elevated PSA levels can be due to either prostate cancer or benign conditions.
Beta HCG Quantitative: This test measures the level of the hormone human chorionic gonadotropin (HCG) in the blood. While HCG is produced by the cells of the placenta during pregnancy in a female, the male testes also produce this hormone at low levels throughout life. In some cancers, including testicular cancer, high levels of HCG are released so its presence in the serum is always considered a malignancy in males.
Comprehensive Male Cancer Package
8 TESTS 1300 AED
- Male Cancer Screening
- Alpha Feto Protein (AFP)
- CA – 19.9
- Carcino Embryonic Antigen (CEA)
- PSA-total Prostate Specific Antigen, total
- Free PSA (Prostate Specific Antigen)
- Beta HCG Quantitative
- Occult blood Stool
- GP Doctor Consultation
- Ultrasound (USG) Whole Abdomen
At the heart of this package are 6 cancer marker tests, which are crucial in detecting the presence of cancer in your body. These tests are designed to identify specific proteins and substances produced by cancer cells, allowing your doctor to detect the disease in its earliest stages.
In addition to the cancer marker tests, you will also receive an ultrasound of your whole abdomen and a doctor consultation. This gives you the opportunity to discuss the results of your tests, ask any questions you may have, and receive personalized recommendations for your next steps. Why wait? Book an appointment today!
Some of the profiles/ tests that we cover in this package are:
- Alpha Feto Protein (AFP): A protein normally made by the liver and yolk sac of a developing baby, AFP levels go down soon after birth and are not seen in a healthy adult. Its presence is elevated in potential cancers, including testicular and liver cancer, in men.
- CA-19.9: A protein that exists on the surface of certain cancer cells, CA 19.9 is shed by the tumour cells and can be detected by lab tests in blood and other body fluids. Elevated levels of the protein is an indicator of cancers such as pancreatic, colorectal, and gastric cancers in men.
- Carcino Embryonic Antigen (CEA): This is a protein present in the gastrointestinal tract during foetal life. Babies in the womb have high levels of CEA and after birth, levels drop dramatically. Therefore, the level of CEA in the blood is relatively low unless certain diseases, including certain cancers are present. Hence, this tumour marker is used to monitor the progression of cancer, particularly in those who have already been diagnosed with cancer.
- PSA- PSA is a protein produced by normal, as well as malignant, cells of the prostate gland. PSA may exist in two forms: It may be bound to another protein or float freely. Our panel measures both, total PSA and Free PSA. A person may have an increased risk of prostate cancer when they have higher levels of total PSA and lower levels of free PSA. Elevated PSA levels can be due to either prostate cancer or benign conditions.
Beta HCG Quantitative: This test measures the level of the hormone human chorionic gonadotropin (HCG) in the blood. While HCG is produced by the cells of the placenta during pregnancy in a female, the male testes also produce this hormone at low levels throughout life. In some cancers, including testicular cancer, high levels of HCG are released so its presence in the serum is always considered a malignancy in males.